Autopsy report · NCT04685421

Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery

“PI, Christopher Tirotta, no longer at NCH as of 5-26-23.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Nicklaus Children's Hospital f/k/a Miami Children's Hospital

Sponsor type

University, hospital or other

Conditions

Cardiac Conditions

Interventions

Bupivacaine liposome

Participants

15

Sites

1

Countries

United States

Trials that died the same way

• Treatment of Chorioamnionitis After Delivery
  “PI retired” (59% match in meaning)
• Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
  “PI leaving NIH.” (58% match in meaning)
• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
  “PI left NIH.” (57% match in meaning)
• Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine
  “PI is no longer here.” (57% match in meaning)
• Uncontrolled Hypertension Management (TEAM-HTN)
  “PI retired before recruitment was started.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.